Ilika plc Commercialisation is in the ascendency

Ilika Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Ilika Plc (LON:IKA) is the topic of conversation when we caught up with Liberum Equity Research Analyst, Sam Wahab. We asked Sam:

What were the key points investors should be aware of?

First deliveries to Blink Energy and now to CubeWorks and Lura Health suggests commercialisation of Ilika’s medical SSBs is in the ascendency. Ongoing discussions with Cirtec remain encouraging with regards to Stereax outsourcing to the US and we would not be surprised to see a positive near-term outcome. At Goliath, the company is targeting Li-ion energy density parity by the end of 2023(currently >80%) ahead of implementing a scale-up to mega-factory scale in order to support a commercial roll-out of a small portfolio of electric hyper and super car models. Ilika’s share price (albeit +100% YTD) continues to reflect material value to investors in our view.

Have you adjusted your forecasts in any way?

No change as yet, but once details of existing shipments are made public (i.e quantity, ASP etc) and discussions conclude with Cirtec – we will revisit.

How do you see the company in terms of fair value?

Currently we model Stereax on a FY25E 20x multiple on 30,000 units sold which is very conservative given recent events. Goliath is on 20x 2040E EV/EBITDA. Overall 60p/share TP ahead of details outlined above – scope to revisit once we have more information on shipments/discussions etc.

Ilika is a pioneer in solid state battery technology, enabling solutions for applications such as Industrial IoT, MedTech, EV and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Ilika publishes 2025 Annual Report, advancing Goliath and Stereax

Ilika plc has released its 2025 Annual Report, outlining progress on Stereax licensing with Cirtec and Goliath EV battery milestones, including customer-validated P1 cells and delivery of a 50Ah prototype.

Ilika: Advancing micro-battery technology with Stereax milestone (LON:IKA)

Ilika CEO Graeme Purdy discusses the completion of manufacturing qualification for Stereax micro batteries at Cirtec’s US facility. With production underway, Ilika plans to begin customer deliveries by year-end. Purdy highlights the batteries’ compact, high-power design tailored for medical applications, and reinforces Cirtec’s strategic role in scaling commercial operations.

Ilika hits Stereax production milestone with Cirtec, Cavendish

Cavendish frames the update as a substantial de risking event. The commissioning phase in January 2025 was a vital precursor, and the latest qualification work represents the final technical validation before production.

Ilika plc Stereax Micro Batteries Enter Production with Customer Deliveries on the Horizon (Video)

CEO Graeme Purdy shares a pivotal update on the company’s Stereax micro batteries as they complete manufacturing qualification and move into production.

Ilika CEO discusses year-end results, Stereax and Goliath progress (LON:IKA)

Graeme Purdy, Ilika Plc’s Chief Executive Officer, speaks to DirectorsTalk about the company’s strong year‑end results, the strategic alignment with Cirtec for Stereax manufacturing and the latest Goliath milestones.

Ilika wins £1.25m APC grant for Goliath A-Samples (LON:IKA)

Ilika has secured £1.25m from the Advanced Propulsion Centre’s Demonstrate fund within the Government’s new £2.5bn Drive35 programme, supporting a £3m, 12-month PRIMED project with HSSMI and UKBIC to produce Goliath A-Samples.

Search

Search